News
New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine ...
In a study published Wednesday in the Proceedings of the National Academy of Sciences, University of Oklahoma researchers ...
Tumor-treating fields (TTFields) therapy and chemoradiation therapy (CRT) may have significant anti-tumor efficacy in ...
1d
News-Medical.Net on MSNZIP4 protein identified as driver of glioblastoma aggressionIn a study published Wednesday in the Proceedings of the National Academy of Sciences (PNAS), University of Oklahoma researchers detail their discoveries about why the brain tumor glioblastoma is so ...
Here’s a look at some of the most recent discoveries from UCLA scientists that are helping to advance more effective and targeted treatment strategies for glioblastoma and other aggressive brain ...
Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...
Following this standard treatment regimen, the rodents develop recurrent tumors, establishing what is referred to as an ...
Boston College researchers contribute to new report on using a ketogenic diet to combat an aggressive brain tumor A ... metabolic therapy (KMT) without chemo or radiation interventions, on a patient ...
A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging ... and has very few treatment options. Chemotherapy, radiation, and surgery only work for ...
is the most aggressive and lethal form of primary brain tumor. Classified as a Grade 4 glioma by the World Health Organization (WHO), glioblastoma presents significant challenges for treatment due to ...
is the most aggressive and lethal form of primary brain tumor. Classified as a Grade 4 glioma by the World Health Organization (WHO), glioblastoma presents significant challenges for treatment due to ...
MSD has acquired Yale University spinout Modifi Biosciences, claiming ownership of a potential new class of therapeutics for difficult-to-treat brain ... resistance to cancer therapy," commented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results